174 related articles for article (PubMed ID: 38292182)
21. LINC00960 affects osteosarcoma treatment and prognosis by regulating the tumor immune microenvironment.
Zhang Y; Lu G; Guan Y; Xu T; Duan Z; Li G
Heliyon; 2024 Feb; 10(3):e24990. PubMed ID: 38352756
[TBL] [Abstract][Full Text] [Related]
22. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
[TBL] [Abstract][Full Text] [Related]
23. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
25. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
[TBL] [Abstract][Full Text] [Related]
26. Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis.
Ye Y; Jiang H; Wu Y; Wang G; Huang Y; Sun W; Zhang M
Front Mol Biosci; 2022; 9():1001225. PubMed ID: 36213111
[No Abstract] [Full Text] [Related]
27. Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer.
Xie X; Liang H; Jiangting W; Wang Y; Ma X; Tan Z; Cheng L; Luo Z; Wang T
Front Mol Biosci; 2023; 10():1198557. PubMed ID: 37484531
[No Abstract] [Full Text] [Related]
28. Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.
Ma P; Sun W
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14597-14617. PubMed ID: 37580402
[TBL] [Abstract][Full Text] [Related]
29. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X; Wen Z; Wang Q; Ren L; Zhao S
Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
[TBL] [Abstract][Full Text] [Related]
31. Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker.
Jin H; Qin S; He J; Xiao J; Li Q; Mao Y; Zhao L
Front Immunol; 2022; 13():1046044. PubMed ID: 36466919
[TBL] [Abstract][Full Text] [Related]
32. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
33. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
[TBL] [Abstract][Full Text] [Related]
34. Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response.
Li Z; Li Y; Tian Y; Li N; Shen L; Zhao Y
Front Immunol; 2023; 14():1170539. PubMed ID: 37275863
[TBL] [Abstract][Full Text] [Related]
35. EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis.
Dai Z; Liu Z; Yang R; Cao W; Ji T
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830696
[TBL] [Abstract][Full Text] [Related]
36. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():927988. PubMed ID: 35756681
[TBL] [Abstract][Full Text] [Related]
37. Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.
Yang B; Su Z; Chen G; Zeng Z; Tan J; Wu G; Zhu S; Lin L
Oncol Lett; 2021 Mar; 21(3):180. PubMed ID: 33574919
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive pan-cancer analysis and the regulatory mechanism of AURKA, a gene associated with prognosis of ferroptosis of adrenal cortical carcinoma in the tumor micro-environment.
Lu K; Yuan X; Zhao L; Wang B; Zhang Y
Front Genet; 2022; 13():996180. PubMed ID: 36685952
[No Abstract] [Full Text] [Related]
39. Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer.
Huang P; Zhou X; Zheng M; Yu Y; Jin G; Zhang S
Front Immunol; 2023; 14():1263537. PubMed ID: 37767092
[TBL] [Abstract][Full Text] [Related]
40. Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers.
Xin Z; Li Y; Meng L; Dong L; Ren J; Men J
Math Biosci Eng; 2022 Jan; 19(2):1825-1842. PubMed ID: 35135230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]